HealthEquity
493 hedge funds and large institutions have $8.38B invested in HealthEquity in 2025 Q3 according to their latest regulatory filings, with 78 funds opening new positions, 165 increasing their positions, 183 reducing their positions, and 63 closing their positions.
200% more call options, than puts
Call options by funds: $20.2M | Put options by funds: $6.72M
24% more first-time investments, than exits
New positions opened: 78 | Existing positions closed: 63
1% more funds holding
Funds holding: 486 → 493 (+7)
0% more funds holding in top 10
Funds holding in top 10: 8 → 8 (0)
10% less repeat investments, than reductions
Existing positions increased: 165 | Existing positions reduced: 183
2.8% less ownership
Funds ownership: 105.52% → 102.73% (-2.8%)
12% less capital invested
Capital invested by funds: $9.56B → $8.38B (-$1.17B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$78.4M |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
+$61.8M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$52.8M |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$43M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
+$42.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$146M |
| 2 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
-$86M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$73.7M |
| 4 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$55.5M |
| 5 |
VBA
Van Berkom & Associates
Montreal,
Quebec, Canada
|
-$46.4M |
HQY Hedge Fund Activity: Q3 2025 in Review
493 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in HealthEquity (HQY) for Q3 2025, worth a combined $8.38B — down 12% from $9.56B a quarter earlier.
Buyers outnumbered sellers: 78 funds opened new HQY positions and 63 closed out — a net gain of 15 holders — while 165 added to existing stakes and 183 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $78.4M. The largest seller was Fidelity Investments, cutting an estimated $146M.
- 493 institutional investors held HealthEquity (HQY) as of Q3 2025, up from 486 in Q2 2025.
- Funds reported $8.38B of HealthEquity stock for Q3 2025, down 12% quarter-over-quarter.
- 78 funds opened new HealthEquity positions in Q3 2025 and 63 closed out, a net change of +15 holders.
- The largest HealthEquity buyer in Q3 2025 was T. Rowe Price Associates, an estimated $78.4M added.
- The largest HealthEquity seller in Q3 2025 was Fidelity Investments, an estimated $146M sold.
Based on aggregated 13F filings for Q3 2025.